跳至主要内容
临床试验/NCT04819256
NCT04819256终止不适用

PACE-It Study : Primary Care Based Integrated Community Care Team Intervention to Improve the Health Outcomes of Patients Living With Diabetes and Complex Needs - a Feasibility Study

SingHealth Polyclinics1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2020年12月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
41
试验地点
1
主要终点
HbA1c

研究概览

简要总结

PACE-It study is a non-blinded, mix-method randomized controlled trial within a single site. This study aims to test the feasibility of implementing a complex intervention comprising of a) a Primary Care Based integrated community care team delivery of person centered care, b) supported by a care co-ordination platform using a mobile application and its effectiveness in improving the glycemic control of patients living with Diabetes and have complex needs.

详细描述

PACE-It study aims to test the feasibility of implementing a complex intervention comprising of a) a Primary Care Based Community Care Team delivery of person centered care b) supported by a care co-ordination platform using a mobile application and its effectiveness in improving the glycemic control of patients living with Diabetes and complex needs.

This is a non-blinded, mix-method randomised controlled trial within the Marine Parade Community. The primary outcome will be glycemic control measure by the Glycated Haemoglobin (HbA1c). Secondary outcomes include blood pressure, LDL-cholesterol, Patient Activation Measure, Medication Adherence and Quality of Life. Data on patient and provider satisfaction and implementation process will be collected by the Qualitative method.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Living within the designated geographical zone
  • •50 years and above
  • •Satisfy the Medical Criteria below:
  • •Diabetes with HbA1c ≥ 9% (within past 6 months), and
  • •At least 1 complication
  • •chronic kidney impairment stage 3 and above, or diabetes overt nephropathy,
  • •ischaemic heart disease, or congestive cardiac failure,
  • •peripheral arterial disease, or diabetes foot/ diabetes foot-related complications,
  • •diabetic retinopathy/ treatment for retinopathy, and
  • •stroke, or transient ischaemic attack
  • •Satisfy at least 2 conditions in the psycho-social, functional or activation domain of which 1 criteria must be from the psycho-social domain:
  • •Psycho-social issues
  • •a. Lack of care giver support i. No care-giver (when indicated) ii. Care-giver skills gap/ stress iii. Inability of copy when patient is the care-giver b. Difficult relationships (family/ workplace/ social network) c. Social isolation/ lack of social connectivity i. Lives alone ii. Lack of social network support d. Financial i. Financial difficulty/ insecurity ii. Housing/ shelter issues iii. Poor money management
  • •Clinical Frailty Score ≥ 4, requiring help in instrumental activities of daily living (iADL)
  • •Requires assistance in ADL or iADL
  • •Activation a. Lack of ability to manage health - disengaged or overwhelmed i. Anxiety or disease-related distress ii. Confusion or lack of understanding of care plans iii. Non-adherence to medications/ follow up
  • •Patient gives consent to participate
  • •For patients who may be seeing a Primary Care Physician (PCP) outside of the polyclinic for chronic disease management and where the PCP has indicated consent to co-manage the patient with the PACE-It team including the polyclinic physician
  • •Patient must be willing to receive care in the polyclinic

排除标准

  • •Patients who are on follow up with Primary Care Physicians or General Practitioners elsewhere for management of their chronic conditions and they do not consent to co-managing patient with the PACE-It team
  • •Patients who have severe cognitive impairment, depression or psychiatric conditions that interfere with the ability to engage with the healthcare team
  • •Patients who are (i) not community ambulant or (ii) bed bound
  • •Patients with terminal illness
  • •Patients who have are in other programs or research studies
  • •Patients who do not give consent

研究组 & 干预措施

Intervention arm

Experimental

Providers use PACE-It mobile application as a care co-ordination platform

干预措施: PACE-It mobile application (Other)

Usual care

No Intervention

Providers use usual modes of communication (e.g., phone calls, emails)

结局指标

主要结局

HbA1c

时间窗: 1 year

Glycemic control

次要结局

  • Patient satisfaction(1 year)
  • Provider's satisfaction(2 years)
  • Blood pressure(1 year)
  • LDL-cholesterol(1 year)
  • Cost-effectiveness(2 years)
  • Patient activation measure (PAM)(1 year)
  • Medication adherence measure (MARS-5)(1 year)
  • EQ-5D-5L(1 year)
  • Implementation of care model(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验